Top Markets
Coin of the day
Bioceltix S.a. Bioceltix S.a.

Bioceltix S.a.

BCX
Rank in Stocks #20676
Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals... Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals for veterinary use. The company’s products include BCX-CM-J, a stem-cell based biological drug for the treatment of osteoarthritis in dogs; BCX-CM-AD, a drug candidate based on allogeneic stem cells for the treatment of atopic dermatitis in dogs; and BCX-EM, a drug candidate based on allogeneic mesenchymal stem cells for the treatment of arthritis in horses. The company was founded in 2016 and is headquartered in Wroclaw, Poland.
Share Price
$22.52
Last synced: 2026-08-21
Market Cap
$124.60M
Change (1 day)
-1.11%
Change (1 year)
-21.94%
Country
PL
Trade Bioceltix S.a. (BCX)

Category

Price of BCX with the market cap of B
Bioceltix S.a. Bioceltix S.a.
BCX
$22.52
Market Capitalization of Bioceltix S.a.(BCX)
Market Cap: $124.60M
As of August 2026 Bioceltix S.a. has a market cap of $124.60M. This makes Bioceltix S.a. the world's 20676th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Bioceltix S.a. from 2021 to 2026
BCX compared with Top 5 Most Popular stocks
Price of BCX Asset B Mkt. of B Results
Bioceltix S.a. Bioceltix S.a.
$942,001 $124.60M
$5.211T +4,182,539.58%
Bioceltix S.a. Bioceltix S.a.
$821,865 $124.60M
$4.547T +3,649,113.88%
Bioceltix S.a. Bioceltix S.a.
$752,405 $124.60M
$4.162T +3,340,699.14%
Bioceltix S.a. Bioceltix S.a.
$649,429 $124.60M
$3.593T +2,883,470.32%
Bioceltix S.a. Bioceltix S.a.
$504,833 $124.60M
$2.793T +2,241,442.15%